References
- Murray C JL, Lopez A D. The global burden of disease. World Health Organization and Harvard University Press, Geneva 1996
- World Health Organization. International classification of impairments, disabilities and handicaps: a manual of classification relating to the consequence of disease. WHO, Geneva 1980
- Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia – summary report. Australian Institute of Health and Welfare, Canberra 1999
- Andrews G, Hall W, Teeson M, Henderson S. The mental health of Australians. Department of Health and Aged Care, Canberra 2000
- Henderson S, Andrews G, Hall W. Australia's mental health: an overview of the general population survey. Australia and New Zealand Journal of Psychiatry 2000; 34: 197–205
- Hays R D, Wells K B, Sherbourne C D, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Archives of General Psychiatry 1995; 52: 11–19
- Wells K B, Stewart A, Hays R D, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. Journal of the American Medical Association 1989; 262: 914–919
- Spitzer R L, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders. Journal of the American Medical Association 1995; 274: 1511–1517
- Spitzer R L, Williams J BW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. Journal of the American Medical Association 1994; 272: 1749–1756
- Boyer P, Bisserbe J-C, Weiller E. How efficient is a screener? A comparison of the PRIME-MD patient questionnaire with the SDDS-PC screen. International Journal of Methods in Psychiatric Research 1997; 7: 27–32
- Australian Bureau of Statistics. ABS, Canberra 1998, SEIFA96 (socio-economic indexes for areas), 1996 census of population and housing. ABS Catalogue No. 2033.4.
- Ware J J, Kosinski M, Keller S D. SF-36 physical and mental health summary scales: a users' manual. Health Institute, New England Medical Center, Boston 1994
- McCallum J. The SF-36 in an Australian sample: validating a new, generic health status measure. Australian Journal of Public Health 1995; 19: 160–166
- Australian Bureau of Statistics. National health Survey: SF-36 Population Norms, Australia. ABS, Canberra 1995, ABS Catalogue No. 4399.0.
- Behavioural Epidemiology Unit. South Australian population norms for the SF-36. South Australian Health Commission, Adelaide 1995
- Hawthorne G, Richardson J, Osborne R, McNeil H. The assessment of quality of life (AQoL) instrument: construction initial validation and utility scaling. Monash University, Melbourne 1997, Working Paper 76.
- Hawthorne G, Richardson J, Osborne R. The assessment of quality of life (AQoL) instrument: a psychometric measure of health-related quality of life. Quality of Life Research 1999; 8: 209–224
- SPSS. SPSS for Windows 9.0. SPSS, Chicago 1999
- Cohen J. A power primer. Psychological Bulletin 1992; 112: 155–159
- Reifler D R, Kessler H S, Bernhard E J, Leon A, Martin G. Impact of screening for mental health concerns on health service utilisation and functional status in primary care patients. Archives of Internal Medicine 1996; 156: 2593–2599
- Coulehan J L, Schulber H C, Block M R, Madonia M J, Rodriguez E. Treating depressed primary care patients improves their physical, mental and social functioning. Archives of Internal Medicine 1997; 157: 1113–1120
- Leidy N K, Palmer C, Murray M, Robb J, Revicki D A. Health related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric properties of four self-report measures. Journal of Affective Disorders 1998; 48: 207–214
- Australian Bureau of Statistics. Census of Population and Housing: Customised Tables. ABS, Canberra 1996, Catalogue No. 2031.0.
- Richardson J, Hawthorne G, Peacock S, Day N, McNeil H. Development of the AQoL. Health Economics Update. Newsletter of the Health Economics Unit. Monash University, Melbourne November, 1999; 3
- Rosenbaum J F, Hylan T R. Costs of depressive disorders: a review. Evidence and experience in psychiatry. Vol. 1: depressive disorders, M Maj, N Sartorius. World Psychiatric Association Series, Wiley, Chichester 1999; 401–449
- Donoghue J. Costs of treating depression: policy should be evidence-based. Evidence and experience in psychiatry. Vol. 1: depressive disorders, M Maj, N Sartorius. World Psychiatric Association Series, Wiley, Chichester 1999; 459–461
- Rutz W, Carlsson P, von Knorring L, Walinder J. Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatrica Scandinavica 1992; 85: 457–464
- Lepine J P, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in the European Society). International Clinical Psychopharmacology 1997; 12: 19–29
- Paykel E S, Priest R G. Recognition and management of depression in general practice: consensus statement. British Medical Journal 1992; 305: 1198–1202
- Priest R G. Improving the management and knowledge of depression. British Journal of Psychiatry 1994; 164: 285–287
- Suominen K H, Isometsa E T, Henriksson M M, Ostano A I, Lonnqvist J K. Inadequate treatment of major depression both before and after attempted suicide. American Journal of Psychiatry 1998; 155: 1778–1780
- Oquendo M A, Malone K M, Ellis S P, Sackeim H, Mann J J. Inadequacy of anti-depressant treatment for patients with major depression who are at risk for suicidal behaviour. American Journal of Psychiatry 1999; 156: 190–194
- Healy D. The three faces of the antidepressants: a critical commentary on the clinical-economic context of diagnosis. Journal of Nervous and Mental Disease 1999; 187: 174–180
- Bebbington P, Hurry J, Tennant C, Sturt E, Wing J K. Epidemiology of mental disorders in Camberwell. Psychological Medicine 1981; 11: 561–579
- Weissman M M, Leaf P J, Tischler G L, et al. Affective disorders in five United States communities. Psychological Medicine 1988; 18: 141–153
- Oakley-Browne M A, Joyce P R, Wells J E, Bushnell J A, Hornblow A R. Christchurch psychiatric epidemiology study. Part II: six month and other period prevalences of specific psychiatric disorders. Australian and New Zealand Journal of Psychiatry 1989; 23: 327–340
- Regier D A, Farmer M E, Rae D S, et al. One-month prevalence of mental disorders in the United States and socio-demographic characteristics: the Epidemiologic Catchment Area Study. Acta Psychiatrica Scandinavica 1993; 88: 35–47
- Kessler L G, McGonagle K M, Zhao S. Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 1994; 51: 8–20
- Tylee A, Gastpar M, Lepine J P, Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. International Clinical Psychopharmacology 1999; 14: 139–151
- Frances A. Problems in defining clinical significance in epidemiological studies. Archives of General Psychiatry 1998; 55: 119
- Spitzer R L. Diagnosis and need for treatment are not the same. Archives of General Psychiatry 1998; 55: 120